follicular lymphoma

(redirected from Follicular non-Hodgkin's lymphoma)
Also found in: Medical, Acronyms.

follicular lymphoma

[fə′lik·yə·lər lim′fō·mə]
(medicine)
A premalignant lymphoma in which the lymph nodes show enlarged follicles composed predominantly of closely packed, large reticuloendothelial cells.
References in periodicals archive ?
ZEVALIN[R] significantly improved 6-year overall survival estimate to 80% in chemorefractory patients with follicular non-Hodgkin's lymphoma (fNHL) who have received nonmyeloablative allogeneic stem cell transplantation, overcoming strong negative prognostic factor of disease chemorefractoriness at transplantation
The article, titled "Biovest - From Chapter 11 to the Edge of Market Filing in EU and Canada" by Mandy Jackson, reports that, "Biovest has been meeting with regulatory officials to make sure it has the clinical data necessary to win approval for the treatment of follicular non-Hodgkin's lymphoma.
OTCQB:ABPI), today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID[R], its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
In the webcast audio interview on OneMedRadio, Biovest discussed its global regulatory strategy for BiovaxID[R], Biovest's personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma.
OTCQB: ABPI), today announced that Biovest is seeking marketing approval in Canada for BiovaxID[R], its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
Santos, Biovest's Senior Vice President, Scientific Affairs, Product Development & Regulatory Affairs, will present an overview of BiovaxID[R], a late-stage personalized cancer vaccine developed in collaboration with the National Cancer Institute for the treatment of follicular non-Hodgkin's lymphoma and other B-cell lymphomas.